Tredje Ap Fonden Boston Scientific Corp Transaction History

Tredje Ap Fonden

$10.8 Billion
Q3 2024

A detailed history of Tredje Ap Fonden transactions in Boston Scientific Corp stock. As of the latest transaction made, Tredje Ap Fonden holds 796,483 shares of BSX stock, worth $69.3 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

796,483

Previous 1,016,483 21.64%

Holding current value

$69.3 Million

Previous $78.3 Million 14.73%

% of portfolio

0.62%

Previous 0.76%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$72.96 - $84.0 $16.1 Million - $18.5 Million	-220,000 Reduced 21.64%	796,483 $66.7 Million
Q2 2024 Aug 12, 2024	SELL	$67.33 - $77.71 $11 Million - $12.7 Million	-164,044 Reduced 13.9%	1,016,483 $78.3 Million
Q1 2024 May 13, 2024	BUY	$57.6 - $68.62 $2.07 Million - $2.47 Million	36,000 Added 3.15%	1,180,527 $80.9 Million
Q4 2023 Feb 12, 2024	BUY	$48.64 - $57.81 $1.87 Million - $2.23 Million	38,510 Added 3.48%	1,144,527 $66.2 Million
Q3 2023 Nov 09, 2023	BUY	$50.19 - $54.68 $487,344 - $530,942	9,710 Added 0.89%	1,106,017 $58.4 Million
Q2 2023 Aug 11, 2023	SELL	$49.72 - $54.64 $1.65 Million - $1.81 Million	-33,160 Reduced 2.94%	1,096,307 $59.3 Million
Q1 2023 May 10, 2023	BUY	$45.09 - $50.03 $2.15 Million - $2.38 Million	47,607 Added 4.4%	1,129,467 $56.5 Million
Q4 2022 Feb 10, 2023	BUY	$39.56 - $47.22 $21.2 Million - $25.3 Million	535,404 Added 97.98%	1,081,860 $50.1 Million
Q3 2022 Nov 10, 2022	BUY	$36.71 - $109.66 $10.1 Million - $30.1 Million	274,714 Added 101.09%	546,456 $21.2 Million
Q1 2022 May 09, 2022	BUY	$40.9 - $45.1 $613,500 - $676,500	15,000 Added 5.84%	271,742 $12 Million
Q4 2021 Feb 10, 2022	BUY	$38.07 - $44.87 $1.41 Million - $1.67 Million	37,153 Added 16.92%	256,742 $10.9 Million
Q3 2021 Nov 10, 2021	BUY	$41.23 - $45.88 $824,599 - $917,600	20,000 Added 10.02%	219,589 $9.53 Million
Q1 2021 May 10, 2021	SELL	$35.27 - $39.67 $1.2 Million - $1.35 Million	-34,000 Reduced 14.56%	199,589 $7.71 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $4.38 Million - $5.54 Million	132,000 Added 129.94%	233,589 $8.4 Million
Q1 2020 May 11, 2020	BUY	$25.83 - $45.71 $432,187 - $764,819	16,732 Added 19.72%	101,589 $2.8 Million
Q4 2019 Feb 10, 2020	SELL	$37.87 - $45.37 $503,443 - $603,148	-13,294 Reduced 13.54%	84,857 $3.84 Million
Q3 2019 Nov 12, 2019	BUY	$40.31 - $43.45 $48,372 - $52,140	1,200 Added 1.24%	98,151 $3.99 Million
Q1 2019 May 10, 2019	BUY	$32.91 - $40.75 $337,821 - $418,298	10,265 Added 11.84%	96,951 $3.72 Million
Q4 2018 Feb 11, 2019	BUY	$31.73 - $39.04 $65,332 - $80,383	2,059 Added 2.43%	86,686 $3.06 Million
Q2 2018 Aug 09, 2018	SELL	$26.84 - $34.32 $1.41 Million - $1.8 Million	-52,363 Reduced 38.22%	84,627 $2.77 Million
Q1 2018 May 09, 2018	SELL	$25.2 - $28.54 $205,531 - $232,772	-8,156 Reduced 5.62%	136,990 $3.74 Million
Q4 2017 Feb 12, 2018	BUY	$24.79 - $29.8 $164,853 - $198,170	6,650 Added 4.8%	145,146 $3.6 Million
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $3.64 Million - $4.04 Million	138,496	138,496 $4.04 Million

Others Institutions Holding BSX

# of Institutions

1,537

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $125B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account